Susan G. Komen Greater NYC Supports Breast Cancer Research Initiatives
A recent grant from Susan G. Komen Greater NYC has funded the Breast Health Equity and International Breast Cancer Research Program at Weill Cornell Medicine. The generous $100,000 Catalyst Research Grant will support the program in addressing breast-cancer disparities through a multi-pronged approach. The program is led by Englander Institute for Precision Medicine Member Dr. Lisa Newman, chief of the Section of Breast Surgery at NewYork-Presbyterian/Weill Cornell Medical Center and Weill Cornell Medicine and the founding medical director of the International Center for the Study of Breast Cancer Subtypes (ICSBCS).
“Komen Greater NYC’s commitment to reducing disparities in access to breast-cancer care is illuminated by Dr. Lisa Newman’s important and groundbreaking research and work,” says Linda Tantawi, CEO of Susan G. Komen Greater NYC. “We are inspired by Dr. Newman’s discoveries and her commitment to health equity. Komen Greater NYC is proud to partner with Weill Cornell Medicine and Dr. Newman with this Catalyst Grant.”
The grant will support several program initiatives: supporting the growth of the ICSBCS outreach/research program by subsidizing international database management, pathology teams and additional laboratory genetic studies; providing navigation services that assist patients with treatment and take advantage of clinical research opportunities; and strengthening outreach efforts by supporting printed and video educational resources.
“We are extremely grateful to Susan G. Komen Greater New York City for this generous gift,” says Dr. Newman. “These funds will enable our Weill Cornell Medicine Breast Program to continue unique research regarding breast-cancer disparities and to implement important community engagement projects in our diverse metropolitan New York population.”
# # #
The above article originally appeared on the Giving to Weill Cornell Medicine website on December, 22, 2020.